Department of Medicine 3 – Rheumatology and Immunology

Bimekizumab in Patients with Psoriatic Arthritis: 3-Year Results for Overall and Tumor Necrosis Factor Inhibitor (TNFi)-Naive Populations from a Phase 2b Open-Label Extension Study (2021) Mease P, Deodhar A, Merola J, Mcinnes I, Assudani D, Bajracharya R, Coarse J, et al. Conference contribution Neither Add-on nor Withdrawal of Methotrexate Impacts Efficacy of IL12/23 Inhibition in Active PsA: Data from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial on Arthritis, Dactylitis, Enthesitis, Psoriasis, QoL and Function (2021) Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Kellner H, Kiltz U, Rech J, et al. Conference contribution Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial (2021) Venhoff N, Schmidt W, Bergner R, Rech J, Unger L, Tony HP, Mendelson M, et al. Conference contribution Secukinumab Treatment Provides Sustained Resolution of Enthesitis at Individual Joints Through 52 Weeks in a Phase 3b, Double-Blind, Randomized, Active-Controlled Study (2021) Kaeley G, Schett G, Conaghan P, Mcgonagle D, Behrens F, Goupille P, Gaillez C, et al. Conference contribution Persistence on JAK Inhibitors in Daily Practice: Evaluation of the Rhadar-registry (2021) Risser L, Witte T, Bartz-Bazzanella P, Von Der Decken C, Knitza J, Fekete SP, Zink A, et al. Conference contribution Humoral Immune Responses to SARS-CoV2 Infections and upon Vaccination Against SARS-CoV2 (2021) Finzel S, Peter N, Brand C, Fischer B, Keller B, Weigang S, Kochs G, et al. Conference contribution Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease (2021) Haberman R, Herati R, Simon D, Samanovic M, Tuen M, Blank R, Koralov S, et al. Conference contribution A new printable alginate / hyaluronic acid / gelatin hydrogel suitable for biofabrication of in vitro and in vivo metastatic melanoma models (2021) Schmid R, Schmidt S, Detsch R, Horder H, Blunk T, Schrüfer S, Schubert DW, et al. Journal article, Original article Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging (2021) Schmidkonz C, Rauber S, Atzinger A, Götz TI, Soare A, Cordes M, Prante O, et al. Journal article Ga-68-FAPI-04 PET/CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-related interstitial lung disease (2021) Schmidkonz C, Distler J, Treutlein C, Atzinger A, Prante O, Ritt P, Goetz T, et al. Journal article